AMN Stock Recent News

AMN Healthcare is undervalued, trading below $900 million market cap, with strong free cash flow and recent strategic moves to reduce net debt. The sale of Symplr and board expertise in M&A position AMN for further portfolio optimization and potential value-unlocking transactions. Despite recent goodwill impairments and cautious analyst outlooks, AMN's financial initiatives and management actions could attract renewed investor interest.

Strengthening symplr's commitment to helping providers optimize staffing, operations, and outcomes HOUSTON , July 2, 2025 /PRNewswire/ -- symplr® , a leading provider of enterprise healthcare operations software backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners LLC (together with its affiliates, "Charlesbank"), has acquired the Smart Square® scheduling software from AMN Healthcare (NYSE: AMN).

Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management

AMN Healthcare (AMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The consensus price target hints at a 29.3% upside potential for AMN Healthcare (AMN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

DALLAS, June 24, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, announced the election of Celia Huber to its Board of Directors during its annual meeting of shareholders on May 2, 2025. Huber's background includes more than 30 years of experience advising healthcare systems, public and private sector payors and companies on strategy, risk and performance.

AMN Healthcare is undervalued, trading at 3.02x FWD cash flow, with strong demand in therapy and imaging specialties supporting future growth. AI investments and normalization post-COVID-19 are expected to enhance service offerings and drive free cash flow improvements in the coming years. Debt reduction has lowered interest expenses, and a large stock repurchase program signals management's confidence in the company's intrinsic value.

DALLAS, May 27, 2025 (GLOBE NEWSWIRE) -- The time required to schedule a physician appointment in 15 major metropolitan areas has increased by 19% since 2022 and by 48% since 2004, according to a new survey conducted by AMN Healthcare, the nation's leading healthcare workforce solutions company.

Heart of Healthcare Under Pressure: 1 in 3 Nurses Near Retirement as Continued Volatility Persists Heart of Healthcare Under Pressure: 1 in 3 Nurses Near Retirement as Continued Volatility Persists